Pfizer shareholder meeting offers inside look at the pharma industry - STAT

Pfizer shareholder meeting offers inside look at the pharma industry - STAT

Pfizer shareholder meeting offers an inside look at the pharma industry

By GEORGE GOEHL AND FELICIA WONG

JUSTIN SULLIVAN/GETTY IMAGES

As Pfizer's board and shareholders celebrate stunning revenue and profits, it's time to ask why it's drugs cost so much. High R&D isn't the answer.

READ MORE